,138 Viral and bacterial infection of lung organoids have demonstrated functional impact of small molecule inhibitors or pathway activators, including NAD(P)H dehydrogenase quinone 1 (NQO1) with antibiotic cefoxitin or anti-viral Remdesivir to understand mechanisms or drug efficacy.75 The gene discussed is NQO1; the disease is bacterial infectious disease.